廣匯寶信(01293.HK)2021年純利5.52億元 同比增長161.1%
格隆匯3月30日丨廣匯寶信(01293.HK)發佈公吿,截至2021年12月31日止年度,公司錄得收入約人民幣375.826億元,同比增長7.0%,實現毛利人民幣22.858億元,同比增長30.6%,股權持有人應占溢利達人民幣5.520億元,同比增長161.1%,每股盈利人民幣0.19元。
該年度,集團實現新車銷售收入為人民幣330.240億元,較2020年同期上升7.1%,其中豪華及超豪華汽車的銷售收入為人民幣306.219億元,較2020年同期上升9.1%,佔新車銷售收入的92.7%。2021年全年集團的新車整體毛利率為1.5%(2020年:1.2%)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.